PTAB challenges

Proceedings overview

As of May 31, 2026, there are no AIA trial proceedings on file for U.S. Patent 8,589,587. This means the patent has not been subjected to Inter Partes Review (IPR), Post-Grant Review (PGR), or Covered Business Method (CBM) review at the Patent Trial and Appeal Board (PTAB). Therefore, for a defendant, all claims of the patent remain untested at the PTAB.

Strategic summary

Currently, all claims of U.S. Patent 8,589,587 (claims 1-15) are UNTESTED by any AIA trial proceeding at the PTAB. No claims have been canceled or found unpatentable through IPR, PGR, or CBM.

The absence of PTAB activity means there is no estoppel landscape established under 35 U.S.C. § 315(e)(2). Therefore, any potential petitioner is not barred from raising any ground that they raised or reasonably could have raised in an IPR, PGR, or CBM. All prior art grounds (e.g., anticipation under § 102 or obviousness under § 103) are still available for a new PTAB challenge. There is no observed pattern of litigation at the PTAB, as no proceedings have been filed.

Recommended next steps

Since there is no PTAB activity on U.S. Patent 8,589,587, a defendant facing assertion of this patent should consider the following:

• Evaluate the patentability of the claims: Conduct a thorough prior art search and an invalidity analysis to assess the strength of a potential IPR petition. The absence of previous PTAB challenges means this patent has not been "hardened" by surviving such reviews.
• Consider filing a petition: If a strong invalidity case can be made, filing an IPR petition may be a viable strategy to challenge the patent's claims. This could lead to cancellation of claims or a favorable settlement.
• Monitor for future filings: Keep an eye on the PTAB dockets for any new IPR, PGR, or CBM filings against US8589587. The absence of activity to date could be an indicator of various factors, but well-asserted patents often eventually attract IPRs.